Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

被引：0
|
作者：
Gustavo F. Westin
Ajoy L. Dias
Ronald S. Go
机构：
[1] Mayo Clinic,Division of Hematology
来源：
Current Hematologic Malignancy Reports | 2016年 / 11卷
关键词：
Acute myeloid leukemia; Hodgkin lymphoma; Diffuse large B cell lymphoma; Multiple myeloma; Amyloidosis; Hematopoietic stem cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Secondary analysis of large datasets has become a useful alternative to address research questions outside the reach of clinical trials. It is increasingly utilized in hematology and oncology. In this review, we provided an overview of some examples of commonly used large datasets in the USA and described common research themes that can be pursued using such a methodology. We selected a sample of 14 articles on adult hematologic malignancies published in 2015 and highlighted their contributions as well as limitations.
引用
收藏
页码：271 / 279
页数：8
相关论文
共 50 条
  • [1] Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
    Westin, Gustavo F.
    Dias, Ajoy L.
    Go, Ronald S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (04) : 271 - 279
  • [2] CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
    Zhang, Xiaomin
    Zhu, Lingling
    Zhang, Hui
    Chen, Shanshan
    Xiao, Yang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Exploring Old Drugs for the Treatment of Hematological Malignancies
    Gan, F.
    Cao, B.
    Wu, D.
    Chen, Z.
    Hou, T.
    Mao, X.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1509 - 1514
  • [4] Challenges in vaccine therapy in hematological malignancies and strategies to overcome them
    Nahas, Myrna R.
    Avigan, David
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (09) : 1093 - 1104
  • [5] Exploring the nexus of nuclear receptors in hematological malignancies
    Mukesh Kumar Manickasamy
    Anjana Sajeev
    Bandari BharathwajChetty
    Mohammed S. Alqahtani
    Mohamed Abbas
    Mangala Hegde
    Babu Santha Aswani
    Mehdi Shakibaei
    Gautam Sethi
    Ajaikumar B. Kunnumakkara
    Cellular and Molecular Life Sciences, 2024, 81
  • [6] Exploring the nexus of nuclear receptors in hematological malignancies
    Manickasamy, Mukesh Kumar
    Sajeev, Anjana
    BharathwajChetty, Bandari
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Hegde, Mangala
    Aswani, Babu Santha
    Shakibaei, Mehdi
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [7] Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities
    Fulda, S.
    LEUKEMIA, 2014, 28 (07) : 1414 - 1422
  • [8] Deubiquitinases in hematological malignancies
    Lei, Hu
    Wang, Jiaqi
    Hu, Jiacheng
    Zhu, Qian
    Wu, Yingli
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [9] SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
    Alvaro Andrades
    Paola Peinado
    Juan Carlos Alvarez-Perez
    Juan Sanjuan-Hidalgo
    Daniel J. García
    Alberto M. Arenas
    Ana M. Matia-González
    Pedro P. Medina
    Molecular Cancer, 22
  • [10] Challenges and optimal strategies of CAR T therapy for hematological malignancies
    Zhang, Yajing
    Xu, Yang
    Dang, Xiuyong
    Zhu, Zeyu
    Qian, Wenbin
    Liang, Aibin
    Han, Weidong
    CHINESE MEDICAL JOURNAL, 2023, 136 (03) : 269 - 279
12345